Abstract:The AMP-activated protein kinase(AMPK) serves as a fuel gauge activated under metabolic stresses which is usually accompanied by increasing intracellular levels of AMP or the ration of AMP to ATP.As a result,AMPK stimulates fatty acid oxidation to generate more ATP and inhibits ATP-consuming processes in coping with stresses and assuring acute cell surviving programs.Since several clinically used anti-diabetic drugs activate AMPK,it is regarded as a promising and effective drug target for type 2 diabetes.Using 5-aminoimidazole-4-carboxamide 1-D-ribonucleoside(AICAR),a cell permeable agent that is phosphorylated inside cells and converted to ZMP,an analog of AMP and a canonical pharmacological AMPK activator,we explored the effect of AMPK on energy metabolism and the insulin signaling pathway in adipocytes.Our results showed that when AMPK was activated,the concentration of malonyl-CoA,an inhibitor of fatty acid oxidation and an intermediate in fatty acid synthesis,diminished by 80%.They also showed that AICAR activated AMPK in differentiated 3T3-F442a adipocytes and enhanced insulin stimulated Akt/PKB activation as well as GSK3βphosphorylation.In contrast,the ability of insulin to activate mTOR,a critical kinase for protein synthesis,was impaired by preincubation of cells with AICAR.This led to a decrease in the phosphorylation of downstream effectors of mTOR,including p70S6K,S6 and 4E-BP1.Furthermore,our results revealed that AMPK directly phosphorylated mTOR and inhibited its autokinase activity in vitro and that AMPK activation by 2-deoxide glucose caused an inhibition of mTOR in MEF cells deficient in TSC2.Thus,our results for the first time demonstrate that AMPK phosphorylates mTOR which leads to the inhibition of its kinase activity and indicate that AMPK regulates mTOR at multiple levels.Collectively,these studies suggest that AMPK exerts a global effect on energy metabolism in adipocytes in which it inhibits both fatty acid and protein synthesis and stimulates fatty acid oxidation.

Novel Small-Molecule Ampk Activator Orally Exerts Beneficial Effects on Diabetic Db/Db Mice

Novel Small-Molecule AMP-Activated Protein Kinase Allosteric Activator with Beneficial Effects in Db/db Mice

High-Throughput Assay for Modulators of Mitochondrial Membrane Potential Identifies a Novel Compound with Beneficial Effects on Db/db Mice

AMPK activator C24 inhibits hepatic lipogenesis and ameliorates dyslipidemia in HFHC diet-induced animal models

Development of Novel Alkene Oxindole Derivatives As Orally Efficacious AMP-Activated Protein Kinase Activators.

AMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome

A Novel SIRT1 Activator E6155 Improves Insulin Sensitivity in Type 2 Diabetic KKAy Mice

The Role of AMPK in Regulation of the Insulin Signal Transduction Pathway

The aldolase inhibitor aldometanib mimics glucose starvation to activate lysosomal AMPK

Effects of kaempherol-3-rhamnoside on metabolic enzymes and AMPK in the liver tissue of STZ-induced diabetes in mice

AMPK Activators As Novel Therapeutics for Type 2 Diabetes

AMPK is associated with the beneficial effects of antidiabetic agents on cardiovascular diseases

Small Molecule Antagonizes Autoinhibition and Activates AMP-activated Protein Kinase in Cells

Combretastatin A-4 Activates AMP-activated Protein Kinase and Improves Glucose Metabolism in Db/db Mice.

DW14006 as a Direct AMPK Activator Ameliorates Diabetic Peripheral Neuropathy in Mice

Salvianolic Acid B Ameliorates Hyperglycemia and Dyslipidemia in db/db Mice through the AMPK Pathway

The Protective Effect of 11-Keto-β-Boswellic Acid against Diabetic Cardiomyopathy in Rats Entails Activation of AMPK

Discovery of AdipoRon Analogues As Novel AMPK Activators Without Inhibiting Mitochondrial Complex I.

Identification of a novel hypoglycemic small molecule, trans-2, 4-dimethoxystilbene by rectifying gut microbiota and activating hepatic AMPKα-PPARγ pathway through gut-liver axis

A Novel ALDH2 Activator AD-9308 Improves Diastolic and Systolic Myocardial Functions in Streptozotocin-Induced Diabetic Mice

Baicalein, a natural product, selectively activating AMPKα(2) and ameliorates metabolic disorder in diet-induced mice.